Organigram Global (OGI) Asset Utilization Ratio (2019 - 2026)

Organigram Global (OGI) posted quarterly Asset Utilization Ratio of 0.67 for Q1 2026, up 20.68% on a QoQ basis from 0.55 in Q4 2025.

Organigram Global (OGI) Asset Utilization Ratio (2019 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Asset Utilization Ratio for 5 consecutive years, with 0.67 the latest figure, recorded in Q1 2026.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.67 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.67 (changed N/A YoY) and the FY2025 annual result came in at 0.51, changed N/A from the prior year.
Asset Utilization Ratio improved to 0.67 in Q1 2026 per OGI's latest filing, from 0.55 in the prior quarter.
Over the last five years, Asset Utilization Ratio for OGI reached as high as 0.67 in Q1 2026 and fell as low as 0.55 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	0.43
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	0.62
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	0.46
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	0.43
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	0.39
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	0.65
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	0.37
10	Organigram Global	89.89 Mn	122.96 Mn	28.97 Mn	0.67

Download Data